Biden’s Act Leads to Record-High Medicare Premium Increase for Seniors
TL/DR –
The article criticizes Biden’s Inflation Reduction Act (IRA) for its unintended consequences, particularly on the healthcare industry and specifically on out-of-pocket maximums for Medicare Part D. The IRA lowered the out-of-pocket maximum for seniors from $3,300 to $2,000, shifting $1,300 of the burden to insurance companies, who then transferred this cost to consumers through higher premiums and restricted access to prescription drugs. The author also notes that the number of prescription drug plans has drastically reduced, leading to less competition and increasing prices, and asserts that the Biden administration’s policies are negatively affecting the American healthcare system.
The Inflation Reduction Act (IRA) and its Impact on American Healthcare
The Obama/Biden strategy often consists of short-term policies that only reveal their long-term consequences after elections, insulating Democrats from voter backlash. This tactic is evident in the Biden administration’s Inflation Reduction Act (IRA), a legislation that has negatively impacted not just the American economy but also public health.
The IRA includes a poorly constructed provision aimed at reducing prescription drug expenses. It has lowered the out-of-pocket maximum for seniors from approximately $3,300 to $2,000, shifting the $1,300 difference onto insurance companies. Predictably, these companies have compensated by increasing premiums and limiting access to prescription drugs.
As a result, Medicare Part D premiums have risen by over 20% for the more than 50 million Americans enrolled. By 2025, they could potentially rise by another 50%. While Biden professes to have “fought Big Pharma to lower drug costs”, consumers may experience a significant price spike during the October open enrollment.
The original design of the Medicare Part D program, established 20 years ago, was centered around a free market principle of competition to sustain low costs and save seniors money. This led to a larger pool of private plans competing, providing better choices and more control to older Americans. This competition also saved seniors money.
However, the Biden administration is looking to reverse these benefits. Part D insurers are reducing costs by adding more “prior authorization” requirements, which steer patients towards the cheapest rather than the most effective therapies. Additionally, some companies are exiting the market altogether. In 2024, the number of available prescription drug plans was less than half of its initial count, marking the smallest selection in the program’s 20-year history.
With reduced competition, prices will rise, making it harder for beneficiaries to afford medication. This will especially affect those on fixed and low incomes. A study found that the number of Part D plans available to low-income beneficiaries has dropped by a third in the past year alone.
One major health plan, Mutual of Omaha, plans to withdraw from the Part D market by 2025. This could leave almost 200,000 seniors in Rust Belt swing states searching for a new plan amidst dwindling options. Without changes, this problem will only worsen, leaving seniors with fewer options while Democrats claim they are offering help.
Alongside economic and immigration issues, the Biden administration’s policies have damaged the American healthcare system. Many people are starting to recognize the deceptive strategies in their playbook, as evidenced by public dissatisfaction with the administration’s handling of healthcare issues. If Republicans win in November, they will have the challenging task of reversing these adverse effects.
—
Read More US Economic News